Measuring health-related quality of life in chronic headache: A comparative evaluation of the Chronic Headache Quality of Life Questionnaire and Headache Impact Test (HIT-6).


Journal

Cephalalgia : an international journal of headache
ISSN: 1468-2982
Titre abrégé: Cephalalgia
Pays: England
ID NLM: 8200710

Informations de publication

Date de publication:
09 2021
Historique:
pubmed: 5 5 2021
medline: 15 12 2021
entrez: 4 5 2021
Statut: ppublish

Résumé

To compare the quality and acceptability of a new headache-specific patient-reported measure, the Chronic Headache Quality of Life Questionnaire (CHQLQ) with the six-item Headache Impact Test (HIT-6), in people meeting an epidemiological definition of chronic headaches. Participants in the feasibility stage of the Chronic Headache Education and Self-management Study (CHESS) (n = 130) completed measures three times during a 12-week prospective cohort study. Data quality, measurement acceptability, reliability, validity, responsiveness to change, and score interpretation were determined. Semi-structured cognitive interviews explored measurement relevance, acceptability, clarity, and comprehensiveness. Both measures were well completed with few missing items. The CHQLQ's inclusion of emotional wellbeing items increased its relevance to participant's experience of chronic headache. End effects were present at item level only for both measures. Structural assessment supported the three and one-factor solutions of the CHQLQ and HIT-6, respectively. Both the CHQLQ (range 0.87 to 0.94) and HIT-6 (0.90) were internally consistent, with acceptable temporal stability over 2 weeks (CHQLQ range 0.74 to 0.80; HIT-6 0.86). Both measures responded to change in headache-specific health at 12 weeks (CHQLQ smallest detectable change (improvement) range 3 to 5; HIT-6 2.1). While both measures are structurally valid, internally consistent, temporally stable, and responsive to change, the CHQLQ has greater relevance to the patient experience of chronic headache.

Identifiants

pubmed: 33942667
doi: 10.1177/03331024211006045
pmc: PMC8411468
doi:

Banques de données

ISRCTN
['ISRCTN79708100']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1100-1123

Références

Cephalalgia. 2012 Jul;32(9):710-4
pubmed: 22707519
J Clin Epidemiol. 2010 Jul;63(7):737-45
pubmed: 20494804
Headache. 2000 Mar;40(3):204-15
pubmed: 10759923
Qual Life Res. 2014 Feb;23(1):257-69
pubmed: 23868457
J Eval Clin Pract. 2017 Dec;23(6):1348-1354
pubmed: 28758322
Cephalalgia. 2018 Mar;38(3):551-560
pubmed: 28944686
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
Cephalalgia. 2011 Feb;31(3):357-67
pubmed: 20819842
Headache. 2012 Mar;52(3):409-21
pubmed: 21929662
BMC Med. 2011 Jul 14;9:86
pubmed: 21756344
J Clin Epidemiol. 2008 Feb;61(2):102-9
pubmed: 18177782
Qual Life Res. 2007 Sep;16(7):1231-7
pubmed: 17468941
Cephalalgia. 2009 Nov;29(11):1180-7
pubmed: 19830883
J Psychosom Res. 2019 Jan;116:83-92
pubmed: 30654999
J Clin Epidemiol. 2006 Apr;59(4):374-80
pubmed: 16549259
J Clin Epidemiol. 2009 Oct;62(10):1062-7
pubmed: 19230609
Health Qual Life Outcomes. 2014 Aug 01;12:117
pubmed: 25080874
Qual Life Res. 2013 Jun;22(5):1123-33
pubmed: 22797868
Qual Life Res. 2003 Dec;12(8):963-74
pubmed: 14651415
BMJ Open. 2017 Dec 15;7(12):e019929
pubmed: 29248887
BMC Med Res Methodol. 2019 Feb 11;19(1):30
pubmed: 30744571
Cephalalgia. 2018 Jun;38(7):1374-1386
pubmed: 28920448
Cephalalgia. 2014 Jan;34(1):29-36
pubmed: 23843470
BMJ Open. 2020 Apr 12;10(4):e033520
pubmed: 32284387
Cephalalgia. 2020 Jan;40(1):6-18
pubmed: 31522547
J Headache Pain. 2019 Jan 8;20(1):2
pubmed: 30621592
Rheumatology (Oxford). 2015 Jan;54(1):64-71
pubmed: 25065007
Headache. 2005 Jun;45(6):638-43
pubmed: 15953295

Auteurs

Kirstie L Haywood (KL)

Warwick Research in Nursing, Warwick Medical School, University of Warwick, Coventry, UK.

Felix Achana (F)

Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.
Nuffield Department of Primary Care Health Sciences, Oxford University, Oxford, UK.

Vivien Nichols (V)

Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.

Gemma Pearce (G)

School of Psychology, Social and Behavioural Sciences, Coventry University, Coventry, UK.

Barbara Box (B)

Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.

Lynne Muldoon (L)

Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.

Shilpa Patel (S)

Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.

Frances Griffiths (F)

Social Science and Systems in Health, Warwick Medical School, University of Warwick, Coventry, UK.

Kimberly Stewart (K)

Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.

Martin Underwood (M)

Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.
University Hospitals Coventry and Warwickshire, Coventry, UK.

Manjit M Matharu (MM)

The Headache Group, National Hospital for Neurology and Neurosurgery, University College of London Hospitals NHS Foundation Trust, AC1 London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH